Visalytics
Visalytics
approved EB-2 (NIW)

Research Scientist

Molecular Biology · Iran · 2025-02-28

Processing Time
470 days
Decision Date
2025-02-28
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses urgent medical needs in cancer treatment and impacts the biopharmaceutical industry.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 26 publications, 546 citations, and CIHR funding demonstrates significant expertise.

3 Balance of Interests Met

The petitioner's contributions to public health and medical science make it beneficial to waive the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's authorship of 26 peer-reviewed journal articles (10 as first author) and a total of 546 citations. Evidence included the completion of 3 peer reviews for scientific journals and receipt of research funding from the Canadian Institutes of Health Research (CIHR). These metrics satisfied the Dhanasar prongs by demonstrating the petitioner's influence and position as a leader in the field.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Original Contributions
Reference Letters Dependent

Similar Cases

Postdoctoral Researcher

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 26 days 2025-06-02
The petitioner proposes to continue research in cancer biology, specifically exploring the molecular mechanisms behind tumor progression and drug resistance. This work focuses on identifying novel therapeutic targets to inform the development of advanced combination therapies and precision medicine paradigms. The intended impact is to improve patient survival rates by creating safer and more effective treatment options for cancers that have evolved resistance to conventional therapies.
View Case

Others

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2022-01-10
The petitioner proposes to create novel in vivo models to study cancer development, elucidate protein functions, and uncover the roles of transcriptomic machinery. This work aims to increase the understanding of cell cycle proteins critical for cancer growth to improve cancer treatments and immunotherapies.
View Case

Research Fellow

Biotechnology · Brazil

WeGreened EB-2 (NIW) approved
Maryland 65 days 2022-04-14
The petitioner proposes to continue investigating RNA and RNA-binding proteins implicated in cancer initiation and development. The work focuses on advancing cancer treatment, diagnosis, and prognosis by providing alternative treatments to chemotherapy, radiation, and surgery.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Pennsylvania 162 days 2022-07-19
The petitioner proposes to continue her research in molecular and cellular cancer biology, cancer chemotherapy, and inflammation. Her work focuses on fundamentally transforming cancer biology research and developing improved treatments for cancer to address the national and global health burden of the disease.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Iran

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-02-28.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 470 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,814
Success Rate 53.6%
Sustained 2,046
Dismissed 1,672

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Iran All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist